- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Market Overview
The global Oncology Blood Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Oncology Blood Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oncology Blood Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oncology Blood Testing market has been segmented into:
Blood Protein Testing
Tumor Marker Testing
Others
By Application, Oncology Blood Testing has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncology Blood Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncology Blood Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncology Blood Testing market.
The report offers in-depth assessment of the growth and other aspects of the Oncology Blood Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Oncology Blood Testing Market Share Analysis
Oncology Blood Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncology Blood Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncology Blood Testing sales, revenue and market share for each player covered in this report.
The major players covered in Oncology Blood Testing are:
Guardant Health
Roche
Trovagene
Genomic Health
Pathway Genomics
Bio-Techne
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Oncology Blood Testing Market Overview
1.1 Product Overview and Scope of Oncology Blood Testing
1.2 Classification of Oncology Blood Testing by Type
1.2.1 Global Oncology Blood Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Oncology Blood Testing Revenue Market Share by Type in 2019
1.2.3 Blood Protein Testing
1.2.4 Tumor Marker Testing
1.2.5 Others
1.3 Global Oncology Blood Testing Market by Application
1.3.1 Overview: Global Oncology Blood Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Oncology Blood Testing Market by Regions
1.4.1 Global Oncology Blood Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Oncology Blood Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oncology Blood Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncology Blood Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Blood Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oncology Blood Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Blood Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Guardant Health
2.1.1 Guardant Health Details
2.1.2 Guardant Health Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Guardant Health SWOT Analysis
2.1.4 Guardant Health Product and Services
2.1.5 Guardant Health Oncology Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Oncology Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Trovagene
2.3.1 Trovagene Details
2.3.2 Trovagene Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Trovagene SWOT Analysis
2.3.4 Trovagene Product and Services
2.3.5 Trovagene Oncology Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Genomic Health
2.4.1 Genomic Health Details
2.4.2 Genomic Health Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Genomic Health SWOT Analysis
2.4.4 Genomic Health Product and Services
2.4.5 Genomic Health Oncology Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pathway Genomics
2.5.1 Pathway Genomics Details
2.5.2 Pathway Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pathway Genomics SWOT Analysis
2.5.4 Pathway Genomics Product and Services
2.5.5 Pathway Genomics Oncology Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Techne
2.6.1 Bio-Techne Details
2.6.2 Bio-Techne Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Techne SWOT Analysis
2.6.4 Bio-Techne Product and Services
2.6.5 Bio-Techne Oncology Blood Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Oncology Blood Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncology Blood Testing Players Market Share
3.2.2 Top 10 Oncology Blood Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Oncology Blood Testing Revenue and Market Share by Regions
4.2 North America Oncology Blood Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Oncology Blood Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Oncology Blood Testing Revenue and Growth Rate (2015-2020)
4.5 South America Oncology Blood Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oncology Blood Testing Revenue and Growth Rate (2015-2020)
5 North America Oncology Blood Testing Revenue by Countries
5.1 North America Oncology Blood Testing Revenue by Countries (2015-2020)
5.2 USA Oncology Blood Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Oncology Blood Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Oncology Blood Testing Revenue and Growth Rate (2015-2020)
6 Europe Oncology Blood Testing Revenue by Countries
6.1 Europe Oncology Blood Testing Revenue by Countries (2015-2020)
6.2 Germany Oncology Blood Testing Revenue and Growth Rate (2015-2020)
6.3 UK Oncology Blood Testing Revenue and Growth Rate (2015-2020)
6.4 France Oncology Blood Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Oncology Blood Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Oncology Blood Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Oncology Blood Testing Revenue by Countries
7.1 Asia-Pacific Oncology Blood Testing Revenue by Countries (2015-2020)
7.2 China Oncology Blood Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Oncology Blood Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Oncology Blood Testing Revenue and Growth Rate (2015-2020)
7.5 India Oncology Blood Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Oncology Blood Testing Revenue and Growth Rate (2015-2020)
8 South America Oncology Blood Testing Revenue by Countries
8.1 South America Oncology Blood Testing Revenue by Countries (2015-2020)
8.2 Brazil Oncology Blood Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Oncology Blood Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Oncology Blood Testing by Countries
9.1 Middle East & Africa Oncology Blood Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Oncology Blood Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Oncology Blood Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Oncology Blood Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Oncology Blood Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Oncology Blood Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Oncology Blood Testing Market Forecast by Type (2019-2024)
10.3 Blood Protein Testing Revenue Growth Rate (2015-2025)
10.4 Tumor Marker Testing Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Oncology Blood Testing Market Segment by Application
11.1 Global Oncology Blood Testing Revenue Market Share by Application (2015-2020)
11.2 Oncology Blood Testing Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
12 Global Oncology Blood Testing Market Size Forecast (2021-2025)
12.1 Global Oncology Blood Testing Market Size Forecast (2021-2025)
12.2 Global Oncology Blood Testing Market Forecast by Regions (2021-2025)
12.3 North America Oncology Blood Testing Revenue Market Forecast (2021-2025)
12.4 Europe Oncology Blood Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Oncology Blood Testing Revenue Market Forecast (2021-2025)
12.6 South America Oncology Blood Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Oncology Blood Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Oncology Blood Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncology Blood Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncology Blood Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Oncology Blood Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Guardant Health Corporate Information, Location and Competitors
Table 6. Guardant Health Oncology Blood Testing Major Business
Table 7. Guardant Health Oncology Blood Testing Total Revenue (USD Million) (2017-2018)
Table 8. Guardant Health SWOT Analysis
Table 9. Guardant Health Oncology Blood Testing Product and Solutions
Table 10. Guardant Health Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Roche Corporate Information, Location and Competitors
Table 12. Roche Oncology Blood Testing Major Business
Table 13. Roche Oncology Blood Testing Total Revenue (USD Million) (2018-2019)
Table 14. Roche SWOT Analysis
Table 15. Roche Oncology Blood Testing Product and Solutions
Table 16. Roche Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Trovagene Corporate Information, Location and Competitors
Table 18. Trovagene Oncology Blood Testing Major Business
Table 19. Trovagene Oncology Blood Testing Total Revenue (USD Million) (2017-2018)
Table 20. Trovagene SWOT Analysis
Table 21. Trovagene Oncology Blood Testing Product and Solutions
Table 22. Trovagene Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Genomic Health Corporate Information, Location and Competitors
Table 24. Genomic Health Oncology Blood Testing Major Business
Table 25. Genomic Health Oncology Blood Testing Total Revenue (USD Million) (2017-2018)
Table 26. Genomic Health SWOT Analysis
Table 27. Genomic Health Oncology Blood Testing Product and Solutions
Table 28. Genomic Health Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pathway Genomics Corporate Information, Location and Competitors
Table 30. Pathway Genomics Oncology Blood Testing Major Business
Table 31. Pathway Genomics Oncology Blood Testing Total Revenue (USD Million) (2017-2018)
Table 32. Pathway Genomics SWOT Analysis
Table 33. Pathway Genomics Oncology Blood Testing Product and Solutions
Table 34. Pathway Genomics Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bio-Techne Corporate Information, Location and Competitors
Table 36. Bio-Techne Oncology Blood Testing Major Business
Table 37. Bio-Techne Oncology Blood Testing Total Revenue (USD Million) (2017-2018)
Table 38. Bio-Techne SWOT Analysis
Table 39. Bio-Techne Oncology Blood Testing Product and Solutions
Table 40. Bio-Techne Oncology Blood Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Oncology Blood Testing Revenue (Million USD) by Players (2015-2020)
Table 42. Global Oncology Blood Testing Revenue Share by Players (2015-2020)
Table 43. Global Oncology Blood Testing Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Oncology Blood Testing Revenue Market Share by Regions (2015-2020)
Table 45. North America Oncology Blood Testing Revenue by Countries (2015-2020)
Table 46. North America Oncology Blood Testing Revenue Market Share by Countries (2015-2020)
Table 47. Europe Oncology Blood Testing Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Oncology Blood Testing Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Oncology Blood Testing Revenue by Countries (2015-2020)
Table 50. South America Oncology Blood Testing Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Oncology Blood Testing Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Oncology Blood Testing Revenue Market Share by Countries (2015-2020)
Table 53. Global Oncology Blood Testing Revenue (Million USD) by Type (2015-2020)
Table 54. Global Oncology Blood Testing Revenue Share by Type (2015-2020)
Table 55. Global Oncology Blood Testing Revenue Forecast by Type (2021-2025)
Table 56. Global Oncology Blood Testing Revenue by Application (2015-2020)
Table 57. Global Oncology Blood Testing Revenue Share by Application (2015-2020)
Table 58. Global Oncology Blood Testing Revenue Forecast by Application (2021-2025)
Table 59. Global Oncology Blood Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Oncology Blood Testing Picture
Figure 2. Global Oncology Blood Testing Revenue Market Share by Type in 2019
Figure 3. Blood Protein Testing Picture
Figure 4. Tumor Marker Testing Picture
Figure 5. Others Picture
Figure 6. Oncology Blood Testing Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Global Oncology Blood Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Oncology Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Oncology Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Oncology Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Oncology Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Oncology Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Oncology Blood Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Oncology Blood Testing Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Oncology Blood Testing Revenue Market Share in 2019
Figure 19. Global Top 10 Players Oncology Blood Testing Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Oncology Blood Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Oncology Blood Testing Revenue Market Share by Regions (2015-2020)
Figure 23. Global Oncology Blood Testing Revenue Market Share by Regions in 2018
Figure 24. North America Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 25. Europe Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 27. South America Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 29. North America Oncology Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 30. North America Oncology Blood Testing Revenue Market Share by Countries in 2019
Figure 31. USA Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 32. Canada Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 34. Europe Oncology Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Oncology Blood Testing Revenue Market Share by Countries in 2019
Figure 36. Germany Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 37. UK Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 38. France Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 39. Russia Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 40. Italy Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Oncology Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Oncology Blood Testing Revenue Market Share by Countries in 2019
Figure 43. China Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 44. Japan Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 45. Korea Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 46. India Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 48. South America Oncology Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 49. South America Oncology Blood Testing Revenue Market Share by Countries in 2019
Figure 50. Brazil Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Oncology Blood Testing Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Oncology Blood Testing Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 55. UAE Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Oncology Blood Testing Revenue and Growth Rate (2015-2020)
Figure 58. Global Oncology Blood Testing Revenue Share by Type (2015-2020)
Figure 59. Global Oncology Blood Testing Revenue Share by Type in 2019
Figure 60. Global Oncology Blood Testing Market Share Forecast by Type (2021-2025)
Figure 61. Global Blood Protein Testing Revenue Growth Rate (2015-2020)
Figure 62. Global Tumor Marker Testing Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Oncology Blood Testing Revenue Share by Application (2015-2020)
Figure 65. Global Oncology Blood Testing Revenue Share by Application in 2019
Figure 66. Global Oncology Blood Testing Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 70. Global Oncology Blood Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Oncology Blood Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Oncology Blood Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Oncology Blood Testing Revenue Market Forecast (2021-2025)
Figure 74. Europe Oncology Blood Testing Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Oncology Blood Testing Revenue Market Forecast (2021-2025)
Figure 76. South America Oncology Blood Testing Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Oncology Blood Testing Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
